-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OIJKul98eI14K8Nbf8K8ROIiIrMvw1rJy2TqerPeYSOPf2n3662tiPrZyyd3KXXW k5TbSsLAH4Xe+Ttz7ngIVQ== 0000903423-02-000267.txt : 20020422 0000903423-02-000267.hdr.sgml : 20020422 ACCESSION NUMBER: 0000903423-02-000267 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20020412 FILED AS OF DATE: 20020422 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ICN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000930184 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330628076 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11397 FILM NUMBER: 02617553 BUSINESS ADDRESS: STREET 1: 3300 HYLAND AVE CITY: COSTA MESA STATE: CA ZIP: 92626 BUSINESS PHONE: 7145450100 MAIL ADDRESS: STREET 1: 3300 HYLAND AVE CITY: COSTA MESA STATE: CA ZIP: 92626 FORMER COMPANY: FORMER CONFORMED NAME: ICN MERGER CORP DATE OF NAME CHANGE: 19940915 COMPANY DATA: COMPANY CONFORMED NAME: IRIDIAN ASSET MANAGEMENT LLC/CT CENTRAL INDEX KEY: 0001033427 OWNER IRS NUMBER: 061439577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 BUSINESS ADDRESS: STREET 1: 276 POST RD WEST CITY: WESTPORT STATE: CT ZIP: 06880-4704 BUSINESS PHONE: 2033417800 MAIL ADDRESS: STREET 1: 276 POST ROAD WEST CITY: WESTPORT STATE: CT ZIP: 06880-4704 3 1 iridianf3_4-19.txt OMB APPROVAL -------------------------- OMB Number: 3235-0104 Expires: December 31, 2005 Estimated average burden hours per response.....0.5 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 (Print or Type Responses) - -------------------------------------------------------------------------------- 1. Name and Address of Reporting Person* Iridian Asset Management LLC (see attached Continuation Sheet to Form 3 for additional Reporting Persons) - -------------------------------------------------------------------------------- (Last) (First) (Middle) 276 Post Road West - -------------------------------------------------------------------------------- (Street) Westport CT 06880-4704 - -------------------------------------------------------------------------------- (City) (State) (Zip) - -------------------------------------------------------------------------------- 2. Date of Event Requiring Statement (Month/Day/Year) 4/12/2002 - -------------------------------------------------------------------------------- 3. IRS Identification Number of Reporting Person, if an Entity (Voluntary) - -------------------------------------------------------------------------------- 4. Issuer Name and Ticker or Trading Symbol ICN Pharmaceuticals, Inc. (ICN) - -------------------------------------------------------------------------------- 5. Relationship of Reporting Person to Issuer (Check all applicable) [_] Director [X](1) 10% Owner [_] Officer (give title below) [_] Other (specify below) - -------------------------------------------------------------------------------- 6. If Amendment, Date of Original (Month/Day/Year) - -------------------------------------------------------------------------------- 7. Individual or Joint/Group Filing (Check applicable line) [ ] Form Filed by One Reporting Person [X] Form Filed by More than One Reporting Person ================================================================================ Table I -- Non-Derivative Securities Beneficially Owned ================================================================================ 3. Ownership Form: 2. Amount of Securities Direct (D) or 1. Title of Security Beneficially Owned Indirect (I) 4. Nature of Indirect Beneficial Ownership (Instr. 4) (Instr. 4) (Instr. 5) (Instr. 4) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, par value $0.01 per share 100 (2)(4) (2)(4)(5) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, par value $0.01 per share 108,500 (3)(4) (3)(4)(5) - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ ====================================================================================================================================
Reminder: Report on a separate line for each class of securities beneficially owned or directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 5(b)(v). Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. (Over) SEC 1473 (3-00) Page 1 of 4 FORM 3 (continued) Table II -- Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) ================================================================================ 5. Owner- 3. Title and Amount of Securities ship Underlying Derivative Security Form of 2. Date Exercisable (Instr. 4) Derivative and Expiration Date --------------------------------- 4. Conver- Security: (Month/Day/Year) Amount sion or Direct 6. Nature of ---------------------- or Exercise (D) or Indirect Date Expira- Number Price of Indirect Beneficial 1. Title of Derivative Exer- tion of Derivative (I) Ownership Security (Instr. 4) cisable Date Title Shares Security (Instr. 5) (Instr. 5) - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ ====================================================================================================================================
Explanation of Responses: See Continuation Sheet to Form 3. IRIDIAN ASSET MANAGEMENT LLC /s/ Jeffrey M. Elliott 4/22/02 - --------------------------------- -------------------- ** Signature of Reporting Person Date By: Jeffrey M. Elliott Title: Executive Vice President ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. Page 2 of 4 Continuation Sheet to Form 3 ==================================================================================================================================== Name and Addresses Iridian Asset Management LLC LC Capital Management, LLC CL Investors, Inc. COLE Partners LLC of Reporting Persons 276 Post Road West c/o Iridian Asset c/o Iridian Asset c/o Iridian Asset Westport, CT 06880-4704 Management LLC Management LLC Management LLC 276 Post Road West 276 Post Road West 276 Post Road West Westport, CT 06880-4704 Westport, CT 06880-4704 Westport, CT 06880-4704 Iridian Private Business David L. Cohen Harold J. Levy Value Equity Fund, L.P. c/o Iridian Asset c/o Iridian Asset c/o Iridian Asset Management LLC Management LLC Management LLC 276 Post Road West 276 Post Road West 276 Post Road West Westport, CT 06880-4704 Westport, CT 06880-4704 Westport, CT 06880-4704 Issuer Name and Ticker or Trading Symbol ICN Pharmaceuticals, Inc. (ICN) Date of Event Requiring Statement 4/12/2002 ====================================================================================================================================
Explanation of Responses: 1. Each Reporting Person may be deemed to be a member of a Section 13(d) group (the "Group") that owns more than 10% of the Issuer's outstanding common stock. Except as described in its statement on Schedule 13D filed on March 8, 2002, as amended, or in footnote 5 below, each Reporting Person expressly disclaims beneficial ownership of all shares of the Issuer's common stock held by the Group, other than those securities the Reporting Person holds directly. 2. These securities are held directly by Iridian Asset Management LLC, a Delaware limited liability company ("Iridian"). 3. These securities are held directly by Iridian Private Business Value Equity Fund, L.P., a Delaware limited partnership ("Iridian Private Business"). The general partner of Iridian Private Business is COLE Partners LLC, a Delaware limited liability company ("COLE"). Iridian is the sole member of COLE. 4. The controlling member of Iridian is LC Capital Management, LLC, a Delaware limited liability company ("LC Capital"). The controlling member of LC Capital is CL Investors, Inc., a Delaware corporation ("CL Investors"). Each of Messrs. Cohen and Levy owns 50% of the common stock of CL Investors and, as his principal occupation, serves as a director of CL Investors, as a manager and Principal of LC Capital and as a Principal and portfolio manager of Iridian. 5. Each Reporting Person disclaims beneficial ownership for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, of the securities reported herein except with respect to the Reporting Person's pecuniary interest in such securities. Page 3 of 4 Continuation Sheet to Form 3 ==================================================================================================================================== Name and Addresses Iridian Asset Management LLC LC Capital Management, LLC CL Investors, Inc. COLE Partners LLC of Reporting Persons 276 Post Road West c/o Iridian Asset c/o Iridian Asset c/o Iridian Asset Westport, CT 06880-4704 Management LLC Management LLC Management LLC 276 Post Road West 276 Post Road West 276 Post Road West Westport, CT 06880-4704 Westport, CT 06880-4704 Westport, CT 06880-4704 Iridian Private Business David L. Cohen Harold J. Levy Value Equity Fund, L.P. c/o Iridian Asset c/o Iridian Asset c/o Iridian Asset Management LLC Management LLC Management LLC 276 Post Road West 276 Post Road West 276 Post Road West Westport, CT 06880-4704 Westport, CT 06880-4704 Westport, CT 06880-4704 Issuer Name and Ticker or Trading Symbol ICN Pharmaceuticals, Inc. (ICN) Date of Event Requiring Statement 4/12/2002 ====================================================================================================================================
ADDITIONAL SIGNATURES OF REPORTING PERSONS LC CAPITAL MANAGEMENT, LLC CL INVESTORS, INC. /s/ Jeffrey M. Elliott 4/22/02 /s/ Jeffrey M. Elliott 4/22/02 - ------------------------------------------- ------------------------------------------- By: Jeffrey M. Elliott Date: By: Jeffrey M. Elliott Date: Title: Executive Vice President Title: Executive Vice President CL INVESTORS, INC. COLE PARTNERS LLC /s/ Jeffrey M. Elliott 4/22/02 /s/ Jeffrey M. Elliott 4/22/02 - ------------------------------------------- ------------------------------------------- By: Jeffrey M. Elliott Date: By: Jeffrey M. Elliott Date: Title: President Title: Executive Vice President IRIDIAN PRIVATE BUSINESS VALUE EQUITY FUND, L.P. By: COLE Partners LLC, General Partner /s/ Jeffrey M. Elliott 4/22/02 /s/ David L. Cohen 4/22/02 --------------------------------------- ------------------------------------------- By: Jeffrey M. Elliott Date: David L. Cohen (individually) Date: Title: Executive Vice President /s/ Harold J. Levy 4/22/02 - ------------------------------------------- Harold J. Levy (individually) Date:
Page 4 of 4 -----END PRIVACY-ENHANCED MESSAGE-----